KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹67 Cr | ₹42 Cr | ₹43 Cr | ₹34 Cr | ₹-33 Cr |
What is the latest Cash Flow from Operating Activities ratio of KOPRAN ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹67 Cr |
| Mar2025 | ₹42 Cr |
| Mar2024 | ₹43 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹-33 Cr |
How is Cash Flow from Operating Activities of KOPRAN Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹67 Cr | 59.15 | |
| Mar2025 | ₹42 Cr | -3.04 | |
| Mar2024 | ₹43 Cr | 27.14 | |
| Mar2023 | ₹34 Cr | Positive | |
| Mar2022 | ₹-33 Cr | - | |
Compare Cash Flow from Operating Activities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹1,303.9 Cr | -7.1% | 16.3% | 57.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -7.1% |
16.3% |
57.1% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses